This study aimed to explore the perspectives and experiences of people with type 1 diabetes who use a continuous subcutaneous insulin infusion (CSII) pump combined with a system for continuous glucose monitoring (CGM). The purpose of the study was to assess how psychological, emotional and social factors influence adequate use and optimal outcome of sensor augmented pump therapy, thereby enabling health care professionals to optimally individualize support to these patients.
This qualitative observational study used the Interpretative Phenomenological Approach (IPA) with semi-structured interviews. Participants were Caucasian adults suffering from type 1 diabetes for over 5 years , using sensor-augmented CSII for over 1 year. Three patients had an adequate HbA1c (<53mmol/mol), three had not. The research took place from January to June 2019 at a Dutchoutpatient clinic.
The study revealed themes associated positive or negative outcomes achieving or not achieving glycaemic targets with the technology. Positive outcomes were found in participants who had a more active coping style, who had good social support systems and who engaged in social activities. Negative outcomes were found in participants who were trying to manage concurrent health problems and who expressed negative emotional experiences or social stress/distress.
Strategies for supporting people using sensor augmented pump technology should consider the individual’s emotional, psychological and social capacity to optimize use and results of this therapy.